claim: trial to no recovery from covid-19 with ivermectin or endocrine therapy
evidence_1: this will be a randomized, open-label study to determine if bicalutamide improves the rate of clinical improvement in patients with covid-19.", "this will be a randomized, open-label study to determine if bicalutamide or ivermectin improves the time to clinical improvement in patients with covid-19 over historical controls.")